bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
4.970
0.00 (0.00%)
At close: May 16, 2025, 4:00 PM
4.970
0.00 (0.00%)
After-hours: May 16, 2025, 7:59 PM EDT
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $48.66 million as of May 16, 2025. Its market cap has decreased by -49.84% in one year.
Market Cap
48.66M
Enterprise Value
186.96M
1-Year Change
-49.84%
Ranking
Category
Stock Price
$4.97
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $48.66M, a decrease of -91.73%. That is a compound annual growth rate of -18.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 48.70M | -39.95% |
| Dec 31, 2024 | 81.10M | -46.26% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |